In the new article, members of the STREAM project described how cancer genetics influences the efficacy of current immunotherapies.
Authors of the article: Dr Beata Pyrzynska, Dr Malgorzata Firczuk, Prof. Jakub Golab, Dr Abdessamad Zerrouqi explain why most patients fail to experience complete tumor regressions after immunotherapy. Members of the STREAM project summarize that a precise list of frequently mutated genes that govern interactions between cancer and immune cells in immunotherapy-resistant patients would be of clinical value.
In the previous texts published in our knowledge base, members of STREAM project wrote about
immune checkpoint blockade in cancer treatment, immunotherapy with monoclonal antibodies or STING protein.
To find out more information, please visit our website: http://www.stream.wum.edu.pl/en/knowledge-base/189-cancer-genetics-influences-efficacy-of-current-immunotherapies